ArticleClinical epigenetics2026

Hypomethylation of VTRNA2-1 promoter predicts adverse outcomes in peripheral artery disease.

Ming-Lung Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.